Abstract
This study describes the preparation of radioiodinated anastrozole and epirubicin and their biological evaluation as potential solid tumor imaging gents. Radioiodinated anastrozole and epirubicin were successfully prepared via direct electrophilic substitution reaction at ambient temperature. The radiochemical yields for radioiodinated anastrozole and epirubicin were maximized to 92.9 ± 0.1 and 98.8 ± 0.1 %, respectively by studying different reaction parameters such as substrate amount, chloramine-T, pH of the reaction mixture, reaction temperature and reaction time. They showed in vitro stability up to 4 and 24 h, respectively. The preclinical evaluation and biodistribution in mice bearing solid tumor showed high retention and biological accumulation in solid tumor cells (12.4 and 25.3 % injected activity/g tissue) and high T/NT ratio equal to 4.7 ± 0.1 and 5.2 ± 0.1 at 2 and 1 h post-injection, respectively. Data described before could recommend radioiodinated anastrozole and radioiodinated epirubicin as potential targeting radiopharmaceuticals for solid tumor imaging.
Similar content being viewed by others
References
Harrison L, Blackwell K (2004) Oncologist 9(Suppl 5):31–40
Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE (1998) Radiother Oncol 46:229–237
Vaupel P, Mayer A (2007) Cancer Metastasis Rev 26:225–239
Hu M, Polyak K (2008) Curr Opin Genet Dev 18:27–34
Kurihara H, Honda N, Kono Y, Arai Y (2012) Curr Med Chem 19(20):3282–3289
Junbo Z, Qian Y, Jinfeng H, Yan P, Sheng Y, Yining H, Tingting T, Chenchen Y, Xuebin W (2010) J Radioanal Nucl Chem 283:481–485
Santos-Cuevas CL, Ferro-Flores G, Murphy CA, Ramirez F, Luna-Gutiérrez MA, Pedraza-López M, Garcia-Becerra R, Ordaz-Rosado D (2009) Int J Pharm 375(1-2):75–83
Stober B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidtke R (2006) Eur J Nucl Med Mol Imaging 33(8):932–939
Kanchan K, Sudhanand P, Aruna K, Archana M, Manu J, Meera V, Ambikalmajan MRP, Rama M, Natesan R (2007) Appl Radiat Isot 65(4):382–396
Schottelius M, Wester H (2009) Methods 48(2):161–177
De Barros AL, Cardoso VN, Mota Ld, Leite EA, de Oliveira MC, Alves RJ (2010) Bioorg Med Chem Lett 20(8):2478–2480
Faintuch BL, Teodoro R, Duatti A, Muramoto E, Faintuch S, Smith CJ (2008) Nucl Med Biol 35(4):401–411
Yang DJ, Wallace S, Cherif A, Li C, Gretzer MB, Kim EE, Podoloff DA (1995) Radiology 194(3):795–800
Bakheet SM, Powe J (1998) Semin Nucl Med 28(4):352–358
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) J Nucl Med 33(11):1972–1980
Kubota R, Kubota K, Yamada S, Tada M, Takahashi T, Iwata R, Tamahashi N (1995) J Nucl Med 36(3):484–492
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N (1995) J Nucl Med 36(7):1301–1306
Sugawara Y, Gutowski TD, Fisher SJ, Brown RS, Wahl RL (1999) Eur J Nucl Med 26(4):333–341
Reinhard MJ, Kubota K, Yamada S, Iwata R, Yaegashi H (1997) J Nucl Med 38(2):280–287
Gutowski TD, Fisher SJ, Moon R, Wahl RL (1992) J Nucl Med 33:925–928
Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR (1993) J Nucl Med 34(7):1190–1197
Furumoto S, Shinbo R, Iwata R, Ishikawa Y, Yanai K, Yoshioka T, Fukuda H (2013) J Nucl Med 54(8):1354–1361
Henley T, Reddy MP, Ramaswamy MR, Lilien DL (2004) Clin Nucl Med 29(5):322–323
Yang DJ, Ilgan S, Higuchi T, Zareneyrizi F, Oh CS, Liu CW, Kim EE, Podoloff DA (1999) Pharm Res 16(5):743–750
Carlin S, Zhang H, Reese M, Ramos NN, Chen Q, Ricketts SA (2014) J Nucl Med 55(3):515–521
Hoigebazar L, Jeong JM (2013) Recent Results Cancer Res 194:285–299
Larson SM (1994) J Nucl Med 35(10):1653–1655
Sakr TM, Motaleb MA, Ibrahim IT (2012) J Radioanal Nucl Chem 292(2):705–710
Sakr TM, El-Safoury DM, Awad GA, Motaleb MA (2013) J Label Compd Radiopharm 56(8):392–395
Sakr TM, Essa BM, El-Essawy FA, El-Mohty AA (2014) Radiochemistry 56(1):76–80
Wan W, Yang M, Pan S, Yu C, Wu N (2008) Drug Dev Res 69(8):520–525
De Barros AL, Mota Ld, Ferreira Cde A, Oliveira MC, Góes AM, Cardoso VN (2010) Bioorg Med Chem Lett 20(21):6182–6184
Mallia MB, Subramanian S, Mathur A, Sarma HD, Venkatesh M, Banerjee S (2010) J Label Comp Radiopharm 53(8):535–542
Wang J, Yang J, Yan Z, Duan X, Tan C, Shen Y, Wu w (2011) J Radioanal Nucl Chem 287(2):465–469
Machac J, Krynyckyi B, Kim C (2002) Semin Nucl Med 32(4):276–292
Hruska CB, Conners AL, Jones KN, Weinmann AL, Lingineni RK, Carter RE, Rhodes DJ, O’Connor MK (2014) Eur J Nucl Med Mol Imag Res 4(1):5–18
Hsia CC, Huang FL, Hung LH, Shen LH, Chen CL, Wang HE (2011) Appl Radiat Isot 69(4):649–655
Ding R, He Y, Xu J, Liu H, Wang X, Feng M, Qi C, Zhang J, Peng C (2012) Med Chem Res 21(4):523–530
Kuchar M, Oliveira MC, Gano L, Santos I, Kniess T (2012) Biorg Med Chem Lett 22(8):2850–2855
Rinku B, Dipak KN, Nabanita C, Kamal KH, Sanmoy K, Mita CD (2014) Chem Biol Drug Des 83(1):58–70
Breeman WAP, Hofland LJ, Bakker WH, Pluij M, Koetsveld PM, Jong M, Setyono-Han B, Kwekkeboom DJ, Visser TJ, Lamberts SWJ, Krenning EP (1993) Eur J Nucl Med 20(11):1089–1094
Du C, Ying H, Zhou J, Jiang J, Liu C, Chen J, Wang X, Hu C (2014) Med Oncol 31(2):833–842
Corsetti F, Chianelli M, Cornelissen B, Van de Wiele C, D’Alessandria C, Slegers G, Mather SJ, Di Mario U, Filetti S, Scopinaro F, Signore A (2004) Cancer Biother Radiopharm 19(1):57–63
Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF, Hoctin-Boes G, Houghton J, Locker GY, Tobias JS, Atac Trialists’ G (2005) The Lancet 365(9453):60–62
Gallagher James (2013) BBC News.
Simpson ER (2003) J Steroid Biochem Mol Biol 86(3–5):225–230
Iwata H, Masuda N, Ohno S, Rai Y, Sato Y, Ohsumi S, Hashigaki S, Nishizawa Y, Hiraoka M, Morimoto T, Sasano H, Saeki T, Noguchi S (2013) Breast Cancer Res Treat 139(2):441–451
Haque R, Ahmed SA, Fisher A, Avila CC, Shi J, Guo A, Craig Cheetham T, Schottinger JE (2012) Cancer Med 1(3):318–327
Cuzick J (2005) Anastrozole Drugs Today (Barc.) Pubmed 41(4):227-239.
Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L (2004) Pharmacol Rev 56(2):185–229
Gewirtz D (1999) Biochem Pharmacol 57(7):727–741
Yordanova G, Skrobanskab R, Evangelatovb A (2012) Colloids Surf B Biointerfaces 92:98–105
Lettr´e R, Paweletz N, Werner D, Granzow C (1972) Die Naturwissenschaften 59(2):59–63
Sheeja KR, Kuttan G, Kuttan R (1997) Amala Res Bull 17:73–76
Abu-Zeid M, Hori H, Nagasawa H, Uto Y, Inayama S (2000) Biol Pharm Bull 23(2):195–198
Rhodes BA (1974) Semin Nucl Med 4(3):281–293
Saha GB (2011) Fundamental of nuclear pharmacy, 5th edn. Springer, New York
Puttaswamy M, Sukhdev A, Shubha JP (2009) J Mol Cat A Chem 310(1–2):24–33
Valkonen J, Pitkanen I, Pajunen A (1985) Acta Chemical Scandinavca A 39:711–716
Adam MJ, Wilbur DS (2005) Chem Soc Rev 34(2):153–163
Motaleb MA, El-Kolaly MT, Rashed HM, Abd El-Bary A (2011) J Radioanal Nucl Chem 10:1499–1507
El-Azony KM (2010) J Radioanal Nucl Chem 285:315–320
Tolmachev V, Bruskin A, Sivaev I, Lundqvist H, Sjöberg S (2002) Radiochem Acta 90:229–235
Hunter WM, Greenwood FC (1963) Biochem J 89:114–123
Puttaswamy M, Vaz N (2003) Trans Met Chem 28:409–417
Ramalingaiah, Jagadeesh RV, Puttaswamy (2007) J Mol Cat A 265:70–79
Cynthia BF, Roger KD, Kaumann AJ, Theodore LS, Lutz B (1979) J Mol Pharmacol 12:328–332
Rayudu GVS (1983) Radiotracers for medical appl., CRS series in Radiotracers in Biology and Medicine 11.
Motaleb MA, Moustapha ME, Ibrahim IT (2011) J Radioanal Nucl Chem 10:1069–1076
Khalkhali I, Cutrone JA, Mena IG, Diggles LE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Moss JF, Klein SR (1995) Radiology 196(2):421–426
Palmedo H, Grunwald F, Bender H, Schomburg A, Mallmann P, Krebs D, Biersack HJ (1996) Eur J Nucl Med 23(8):940–946
Barbarics E, Kronauge JF, Davison A, Jones AG (1998) Nucl Med Biol 25(7):667–673
Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Eugemo I, Bernard D, Angelika BD, Leopoldo C, Kenneth M (1989) J Nucl Med 30(3):301–311
Vecchio SD, Ciarmiello A, Potena MI, Carriero MV, Mainolfi C, Botti G, Thomas R, Cerra M, D’Aiuto G, Tsuruo T, Salvatore M (1997) Eur J Nucl Med 24(2):150–159
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ibrahim, A.B., Sakr, T.M., Khoweysa, O.M.A. et al. Radioiodinated anastrozole and epirubicin as potential targeting radiopharmaceuticals for solid tumor imaging. J Radioanal Nucl Chem 303, 967–975 (2015). https://doi.org/10.1007/s10967-014-3560-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10967-014-3560-9